Our goal is to decipher the genetic and neurobiological basis of mental disorders including schizophrenia and autism.
Takeo Yoshikawa, M.D., Ph.D.
Team Leader, Molecular Psychiatry
takeo.yoshikawa [at] riken.jp
- Research Overview
- Selected Publications
- News & Media
- Curriculum Vitae
- MEXT Grant-Aid for Scientific Research on Innovative Areas
Constructive understanding of multi-scale dynamism of neuropsychiatric disorders
Autism spectrum disorders (ASD) and adolescence/adult-onset endogenous psychoses, such as schizophrenia and mood disorders, are relatively common diseases that show a chronic course. Once these diseases develop, the patients' quality of life deteriorates substantially. This is because there are no ideal medical treatments, a reflection of the largely unknown etiology of these illnesses. Considering the immense personal and social losses induced by mental disorders, it is imperative to identify the mechanisms of the diseases, so as to develop fundamental therapies and effective prevention. Our current efforts focus on strategies that aim to identify susceptibility genetic and environmental mechanisms, by employing molecular and behavioral genetic approaches and biochemical analyses that utilize both human samples and animal models. We hope that these endeavors will lead to a better understanding of neuropsychiatric diseases at the molecular level and eventually contribute to improving the welfare of patients suffering from these disorders.
Main Research Field
Medicine, dentistry, and pharmacy
Related Research Fields
- Maekawa M, Watanabe A, Iwayama Y, Kimura T, Hamazaki K, Balan S, Ohba H, Hisano Y, Nozaki Y, Ohnishi T, Toyoshima M, Shimamoto C, Iwamoto K, Bundo M, Osumi N, Takahashi E, Takashima A, Yoshikawa T.:
"Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes"
Translational Psychiatry, 7, e1229; doi:10.1038/tp.2017.182; (2017)
- Gerstner JR, Perron IJ, Riedy SM, Yoshikawa T, Kadotani H, Owada Y, Hans P.A. Van Dongen HPA, Galante R, Dickinson J, Yin JCP, Pack AI, Frank MG.:
"Normal sleep requires the astrocyte brain-type fatty acid binding protein FABP7"
Science Advances, 3: e1602663 (2017)
- Sugiura L*, Toyota T, Matsuba-Kurita H, Iwayama Y, Mazuka R, Yoshikawa T*, Hagiwara H.:
"Age-dependent effects of catechol-O-methyltransferase (COMT) gene Val158Met polymorphism on language function in developing children"
Cerebral Cortex, 27, 104-116 (2016) *Co-corresponding authors
- Toyoshima M, Akamatsu W, Okada Y, Ohnishi T, Balan S, Hisano Y, Iwayama Y, Toyota T, Matsumoto T, Itasaka N, Sugiyama S, Tanaka M, Yano M, Dean B, Okano H, Yoshikawa T.:
"Schizophrenia patient-derived induced pluripotent stem cells exhibit changes in neurogenic and gliogenic competences"
Translational Psychiatry 6: e934 (2016)
- Maekawa M, Yamada K, Toyoshima M, Ohnishi T, Iwayama Y, Shimamoto C, Toyota T, Nozaki Y, Balan S, Matsuzaki H, Iwata Y, Suzuki K, Miyashita M, Kikuchi M, Kato M, Okada Y, Akamatsu W, Mori N, Owada Y, Itokawa M, Okano H, and Yoshikawa T.:
"Utility of scalp hair follicles as a novel source of biomarker genes for psychiatric illnesses"
Biological Psychiatry, 78, 116-125 (2015)
- Shimamoto C, Ohnishi T, Maekawa M, Watanabe A, Ohba H, Arai R, Iwayama Y, Hisano Y, Toyota T, Toyoshima M, Suzuki K, Nakamura K, Mori N, Shirayama Y, Owada Y, Kobayashi T, and Yoshikawa T.:
"Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies."
Hum Mol Genet, 23(24), 6495-6511 (2014)
- Bundo M, Toyoshima M, Okada Y, Akamatsu W, Ueda J, Nemoto-Miyauchi T, Sunaga F, Toritsuka M, Ikawa D, Kakita A, Kato M, Kasai K, Kishimoto T, Nawa H, Okano H, Yoshikawa T, Kato T, and Iwamoto K.:
"Increased L1 Retrotransposition in the Neuronal Genome in Schizophrenia."
Neuron, 81(2), 306-313 (2014)
- Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T, Watanabe M, Takeda A, Tomiyama H, Nakashima K, Hasegawa K, Obata F, Yoshikawa T, Kawakami H, Sakoda S, Yamamoto M, Hattori N, Murata M, Nakamura Y, and Toda T.:
"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease."
Nat Genet, 41(12), 1303-7 (2009)
- Watanabe, A., Toyota, T., Owada, Y., Hayashi, T., Iwayama, Y., Matsumata, M., Ishitsuka, Y., Nakaya, A., Maekawa, M., Ohnishi, T., Arai, R., Sakurai, K., Yamada, K., Kondo, H., Hashimoto, K., Osumi, N., Yoshikawa, T.:
"Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype"
PLoS Biology 5, e297 (2007)
- Yamada, K., Gerber, D.J., Iwayama, Y., Ohnishi, T., Ohba, H., Toyota, T., Aruga, J., Minabe, Y., Tonegawa, S., Yoshikawa, T.:
"Genetic analysis of the calcineurin pathway identifies the EGR family and specifically EGR3, as potential candidates in schizophrenia"
Proc. Natl. Acad. Sci. USA 104, 2815-2820 (2007)
News & Media
Sep. 5, 2017（Press Release）
Nov. 2, 2016（Press Release）
Sep. 12, 2014（Press Release）
Jul. 15, 2014（Press Release）
Nov. 13, 2007（Press Release）
A Candidate Gene for a Biological Marker of Schizophrenia in Mice
Feb. 20, 2007（Press Release）